Payden & Rygel’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Buy |
34,600
+11,820
| +52% | +$3.69M | 0.89% | 54 |
|
|
2025
Q1 | $11.9M | Sell |
22,780
-5,600
| -20% | -$2.93M | 1.03% | 48 |
|
|
2024
Q4 | $14.4M | Buy |
28,380
+23,800
| +520% | +$12M | 1.24% | 38 |
|
|
2024
Q3 | $2.68M | Hold |
4,580
| – | – | 0.21% | 72 |
|
|
2024
Q2 | $2.33M | Sell |
4,580
-25,800
| -85% | -$13.1M | 0.19% | 72 |
|
|
2024
Q1 | $15M | Buy |
30,380
+5,600
| +23% | +$2.77M | 0.71% | 49 |
|
|
2023
Q4 | $13M | Hold |
24,780
| – | – | 0.91% | 58 |
|
|
2023
Q3 | $12.5M | Sell |
24,780
-37,050
| -60% | -$18.7M | 0.85% | 54 |
|
|
2023
Q2 | $29.7M | Sell |
61,830
-11,100
| -15% | -$5.34M | 2.1% | 3 |
|
|
2023
Q1 | $34.5M | Sell |
72,930
-22,280
| -23% | -$10.5M | 2.04% | 10 |
|
|
2022
Q4 | $50.5M | Buy |
95,210
+1,100
| +1% | +$583K | 2.69% | 1 |
|
|
2022
Q3 | $47.5M | Buy |
94,110
+2,400
| +3% | +$1.21M | 2.78% | 2 |
|
|
2022
Q2 | $47.1M | Buy |
91,710
+700
| +0.8% | +$360K | 2.83% | 2 |
|
|
2022
Q1 | $46.4M | Buy |
91,010
+34,300
| +60% | +$17.5M | 2.34% | 5 |
|
|
2021
Q4 | $28.5M | Buy |
56,710
+1,110
| +2% | +$557K | 1.32% | 33 |
|
|
2021
Q3 | $21.7M | Buy |
55,600
+7,700
| +16% | +$3.01M | 1.13% | 46 |
|
|
2021
Q2 | $19.2M | Buy |
47,900
+2,000
| +4% | +$801K | 0.91% | 67 |
|
|
2021
Q1 | $17.1M | Buy |
+45,900
| New | +$17.1M | 0.79% | 68 |
|
|
2016
Q1 | – | Sell |
-191
| Closed | -$22K | – | 210 |
|
|
2015
Q4 | $22K | Buy |
+191
| New | +$22K | ﹤0.01% | 132 |
|